Your browser is no longer supported. Please, upgrade your browser.
Settings
AVDL Avadel Pharmaceuticals plc daily Stock Chart
AVDL [NASD]
Avadel Pharmaceuticals plc
Index- P/E- EPS (ttm)-1.01 Insider Own2.50% Shs Outstand41.24M Perf Week-3.66%
Market Cap379.82M Forward P/E36.12 EPS next Y0.26 Insider Trans- Shs Float40.39M Perf Month-14.41%
Income-41.30M PEG- EPS next Q-0.05 Inst Own70.30% Short Float1.19% Perf Quarter-10.23%
Sales150.20M P/S2.53 EPS this Y-204.40% Inst Trans-2.96% Short Ratio4.27 Perf Half Y-32.92%
Book/sh1.02 P/B9.03 EPS next Y966.70% ROA-16.50% Target Price20.63 Perf Year-14.25%
Cash/sh3.74 P/C2.46 EPS next 5Y- ROE-82.40% 52W Range8.61 - 15.45 Perf YTD-11.36%
Dividend- P/FCF21.46 EPS past 5Y-23.00% ROI-20.50% 52W High-40.39% Beta1.55
Dividend %- Quick Ratio2.90 Sales past 5Y35.70% Gross Margin91.20% 52W Low6.97% ATR0.58
Employees109 Current Ratio2.90 Sales Q/Q-3.40% Oper. Margin-3.30% RSI (14)38.50 Volatility4.77% 6.85%
OptionableYes Debt/Eq3.23 EPS Q/Q-93.50% Profit Margin-27.50% Rel Volume0.69 Prev Close9.29
ShortableYes LT Debt/Eq3.22 EarningsMar 07 BMO Payout- Avg Volume112.13K Price9.21
Recom1.70 SMA20-8.88% SMA50-7.50% SMA200-18.52% Volume77,751 Change-0.86%
Mar-17-17 06:03AM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -5.53%
Mar-07-17 04:08PM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Amendment or Waiver to Code of Ethics, Financial Statements and Exhibi
07:06AM  Avadel tops Street 4Q forecasts
07:00AM  Avadel Pharmaceuticals Announces $25 Million Share Repurchase Program GlobeNewswire
06:30AM  Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Results GlobeNewswire
Mar-02-17 10:01AM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events
07:30AM  Avadel Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Feb-24-17 08:30AM  Avadel Pharmaceuticals (AVDL) Looks Good: Stock Up 5.3%
Feb-16-17 06:37AM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events
Feb-14-17 07:30AM  Avadel Pharmaceuticals to Report Fourth Quarter and Full Year 2016 Results GlobeNewswire
Feb-06-17 03:55PM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events
07:30AM  Avadel Pharmaceuticals to Present at Two Upcoming Investor Conferences GlobeNewswire
Jan-11-17 04:05PM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jan-06-17 01:52PM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events -6.66%
01:04PM  AVADEL PHARMACEUTICALS PLC Financials
Jan-05-17 11:57AM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits +5.18%
08:18AM  CORRECTING and REPLACING Avadel Pharmaceuticals Provides 2017 Guidance and Business Update GlobeNewswire
07:30AM  Avadel Pharmaceuticals Provides 2017 Guidance and Business Update GlobeNewswire
Jan-03-17 04:03PM  Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Commercial Officer GlobeNewswire +5.39%
07:30AM  Flamel Technologies Completes Cross-Border Merger and Becomes Avadel Pharmaceuticals plc GlobeNewswire
Dec-19-16 03:38PM  FLAMEL TECHNOLOGIES SA Files SEC form 8-K, Other Events
Avadel Pharmaceuticals PLC is a pharmaceutical company engaged in drug delivery and formulation development to create safer and more efficacious pharmaceutical products.